Resection: Clinical Trials

72 trials of Resection, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

21 recruiting, 14 completed, 12 active not recruiting, 9 terminated. 24 Phase 2, 23 Phase 1, 8 Not applicable, 6 Phase 3, 4 Early Phase 1.

By phase and status

PhaseTrialsStatus
Phase 224Recruiting 6, Terminated 6, Active not recruiting 4, Completed 4, Withdrawn 2, Not yet recruiting 1, Suspended 1
Phase 123Recruiting 11, Active not recruiting 3, Terminated 3, Withdrawn 3, Completed 2, Not yet recruiting 1
Not applicable8Unknown 3, Completed 2, Recruiting 2, Active not recruiting 1
Phase 36Active not recruiting 3, Recruiting 2, Unknown 1
Early Phase 14Active not recruiting 1, Completed 1, Recruiting 1, Suspended 1
Phase 41Unknown 1

Follow Resection: new trials by email Literature Review of Resection trials Research Report on Resection

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
FPS-ZM1 With or Without Dexamethasone for Controlling Post Operative Cerebral Edema in Patients With Glioblastoma
Biospecimen Collection, Computed Tomography, Dexamethasone - Glioblastoma, Malignant Glioma
Phase 1Not yet recruitingCity of Hope Medical Center242027-02-172026-08-27
Fluorescence-Guided Surgical Resection for Reducing Unexpected Positive Margins in Patients With Sarcoma, SarcoSIGHT Trial
Electronic Health Record Review, Fluorescence Imaging, Fluorescence-Guided Surgery - High Grade Sarcoma, Sarcoma
Phase 2RecruitingCity of Hope Medical Center222026-08-142026-10-16
A Study Comparing Higher Dose Chemotherapy Over a Shorter Amount of Time to Lower Dose Chemotherapy Plus Maintenance Over a Longer Amount of Time in Patients With Newly Diagnosed Intermediate-Risk Rhabdomyosarcoma (IR RMS)
Biospecimen Collection, Bone Marrow Aspiration, Bone Marrow Biopsy - Rhabdomyosarcoma
Phase 3RecruitingChildren's Oncology Group3422026-07-142026-08-25
Locoregional Administration of Genetically Engineered Cells (EGFR/IL13Rα2 Pool-CAR T Cells) for the Treatment of Recurrent or Progressive High-Grade Gliomas
Autologous Anti-EGFR/Anti-IL13Ralpha2 CAR T-cells, Biopsy Procedure, Biospecimen Collection - Recurrent Astrocytoma, IDH-Mutant, Grade 4, Recurrent Glioblastoma, IDH-Wildtype
Phase 1RecruitingCity of Hope Medical Center242026-05-262026-10-23
Zanidatamab Before Surgery for the Treatment of HER2 Positive Colon and Rectal Cancer in Patients Planned for Curative Intent Treatment
Zanidatamab, Resection, Patient Observation - Colon Carcinoma, Colorectal Carcinoma
Phase 2RecruitingEmory University382026-04-072026-04-17
SBRT Versus Surgical Resection for Small HCC
Stereotactic body radiotherapy (SBRT), Resection - Hepatocellular Carcinoma (HCC)
Phase 3RecruitingSun Yat-sen University3902026-03-182026-09-01
An Optimized Ultrasound Twinkling Marker for the Imaging of Lymph Nodes in Patients With Clinically Node-Positive Breast Cancer, The UTMOST2 Trial
Diagnostic Mammography, Resection, Ultrasound Imaging - Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage III Breast Cancer AJCC v8
Phase 1RecruitingMayo Clinic202025-08-292026-09-23
Intracranial Genetically Modified Immune Cells (TGFβR2KO/IL13Rα2 CAR T-Cells) for the Treatment of Recurrent or Progressive Glioblastoma or Grade 3 or 4 IDH-Mutant Astrocytoma
Biospecimen Collection, Chimeric Antigen Receptor T-Cell Therapy, Echocardiography - Recurrent Astrocytoma, IDH-Mutant, Grade 3, Recurrent Astrocytoma, IDH-Mutant, Grade 4
Phase 1RecruitingCity of Hope Medical Center272025-06-172026-10-22
Peptide-Pulsed Dendritic Cell Vaccination in Combination With Nivolumab and Ipilimumab for the Treatment of Recurrent and/or Progressive Diffuse Hemispheric Glioma, H3 G34-mutant
Dendritic Cell Tumor Peptide Vaccine, Ipilimumab, Leukapheresis - Diffuse Hemispheric Glioma, H3 G34-Mutant
Phase 1WithdrawnJonsson Comprehensive Cancer Center2024-12-012025-02-24
Cryodevitalization for the Treatment of Early Stage Lung Cancer, CRYSTAL Trial
Cryosurgery, Robotic Bronchoscopy, Bronchoscopy with Biopsy - Stage I Lung Cancer, Stage II Lung Cancer
Not applicableActive not recruitingVanderbilt-Ingram Cancer Center132024-09-272026-08-18
Triapine in Combination With Temozolomide for the Treatment of Patients With Recurrent Glioblastoma
Biospecimen Collection, Magnetic Resonance Imaging, Questionnaire Administration - Recurrent Glioblastoma, IDH-Wildtype, Recurrent WHO Grade 2 Glioma
Phase 1RecruitingNorthwestern University222024-07-232026-09-09
Testing the Combination of the Anticancer Drug Durvalumab With Chemotherapy (Gemcitabine and Cisplatin) at Improving Outcomes for High-Risk Resectable Liver Cancer Before Surgery
Biopsy Procedure, Biospecimen Collection, Cisplatin - Resectable Intrahepatic Cholangiocarcinoma
Phase 2SuspendedNational Cancer Institute (NCI)272024-07-102026-09-04
Anti-EGFRvIII synNotch Receptor Induced Anti-EphA2/IL-13Ralpha2 CAR (E-SYNC) T Cells
E-SYNC T Cells, Cyclophosphamide (non-investigational), Fludarabine (non-investigational) - EGFR Gene Mutation, Glioblastoma
Phase 1RecruitingHideho Okada, MD, PhD202024-04-302026-08-13
Proton-Spatially Fractionated Radiotherapy and Standard Radiation Therapy for the Treatment of Newly Diagnosed Retroperitoneal Soft Tissue Sarcoma
Biopsy, Biospecimen Collection, Computed Tomography - Retroperitoneal Sarcoma
Phase 1 / Phase 2RecruitingNorthwestern University282024-04-022026-07-07
Neoadjuvant Radio-chemotherapy Safety Pilot Study in Patients With Glioblastoma
hypofractionated stereotactic radiotherapy, Stereotactic biopsy, resection - Glioblastoma, Glioblastoma Multiforme
Phase 1RecruitingHospital San Carlos, Madrid122024-03-212024-05-16
Trotabresib in Combination With Vinorelbine and Radiation Therapy for the Treatment of HER2+ Breast Cancer With Central Nervous System or Leptomeningeal Metastasis
Biospecimen Collection, Computed Tomography, Magnetic Resonance Imaging - Breast Carcinoma, Metastatic Malignant Neoplasm in the Brain
Phase 1WithdrawnNorthwestern University2023-12-312024-04-01
Prospective Evaluation of AI R&D Tool in Adult Glioma and Other Primary Brain Tumours (PEAR-GLIO)
Resection - Brain Tumor, Glioma, Malignant
TerminatedOurotech, Inc.122023-10-122025-07-30
Testing the Addition of Total Ablative Therapy to Usual Systemic Therapy Treatment for Limited Metastatic Colorectal Cancer, ERASur Trial
Stereotactic Ablative Radiotherapy, Resection, Microwave Ablation - Metastatic Colorectal Adenocarcinoma, Stage IV Colorectal Cancer AJCC v8
Phase 2RecruitingAlliance for Clinical Trials in Oncology1462023-10-092026-10-02
Evaluating the Use of Dual Imaging Techniques for Detection of Disease in Patients With Head and Neck Cancer
Panitumumab-IRDye800, Indium In 111 Panitumumab, Single Photon Emission Computed Tomography - Head and Neck Squamous Cell Carcinoma, Recurrent Head and Neck Squamous Cell Carcinoma
Phase 1RecruitingVanderbilt-Ingram Cancer Center402023-10-032025-10-03
Intratumoral Extracellular Metabolic Impact of DFMO and AMXT 1501 in Patients With Diffuse or High Grade Glioma
Biospecimen Collection, Computed Tomography, Eflornithine - Diffuse Glioma, Malignant Glioma
Early Phase 1RecruitingMayo Clinic182023-10-012025-11-04

Showing 20 of 72. Sign in to see all of them.

Conditions studied

Glioblastoma (14)  ·  Carcinoma, Non-Small-Cell Lung (6)  ·  Colorectal Neoplasms (6)  ·  Brain Neoplasms (5)  ·  Lung Neoplasms (5)  ·  Glioma (4)  ·  Rectal Neoplasms (4)  ·  Astrocytoma (3)  ·  Gliosarcoma (3)  ·  Pancreatic Neoplasms (3)  ·  Carcinoma, Hepatocellular (2)  ·  Cholangiocarcinoma (2)  ·  Melanoma (2)  ·  Neoplasm Metastasis (2)  ·  Oligodendroglioma (2)

Sponsors

City of Hope Medical Center (6)  ·  M.D. Anderson Cancer Center (6)  ·  Mayo Clinic (4)  ·  National Cancer Institute (NCI) (3)  ·  Northwestern University (3)  ·  Vanderbilt-Ingram Cancer Center (3)  ·  Alliance for Clinical Trials in Oncology (2)  ·  Children's Oncology Group (2)  ·  Emory University (2)  ·  Jonsson Comprehensive Cancer Center (2)  ·  Radiation Therapy Oncology Group (2)  ·  Sun Yat-sen University (2)  ·  Thomas Jefferson University (2)  ·  Andrew B Lassman, MD (1)  ·  Assistance Publique - Hôpitaux de Paris (1)

Countries

United States (52)  ·  Canada (6)  ·  China (5)  ·  Netherlands (3)  ·  Sweden (2)  ·  Australia (1)  ·  Egypt (1)  ·  France (1)  ·  Germany (1)  ·  New Zealand (1)  ·  Puerto Rico (1)  ·  Saudi Arabia (1)  ·  Spain (1)  ·  Switzerland (1)  ·  United Kingdom (1)

Top investigators

Behnam Badie (2)  ·  Adam C. Berger, MD (1)  ·  Andrew B. Lassman, MD (1)  ·  Andrew Wang, MD (1)  ·  Anthony C Wang (1)  ·  Arkadiusz Dudek, MD (1)  ·  Aslam Ejaz, MD (1)  ·  Bas Groot Koerkamp, MD, PhD (1)  ·  Carlo M Contreras, MD (1)  ·  Charles D Lopez (1)  ·  Chia-Jung Busch, PD Dr. (1)  ·  Christine M Heske (1)  ·  Christine U. Lee, MD, PhD (1)  ·  Cristina R. Ferrone, MD (1)

Results publications

PMID 22543206, PMID 27784746, PMID 30858085, PMID 30926067, PMID 32727416, PMID 35883131, PMID 36239788, PMID 36652155, PMID 37650478, PMID 38350888, PMID 39402027, PMID 40389098, PMID 41177142, PMID 41287448, PMID 41498537

NIH funding

P30CA033572 (6), P30CA060553 (3), P30CA138292 (2), U10CA180886 (2), P30CA014089 (1), P30CA015704 (1), P30CA068485 (1), P30CA093373 (1), P50CA211015 (1), R01CA266233 (1), R01EB033008 (1), R33CA127055 (1), R37CA276851 (1), U01CA154967 (1), U10CA032102 (1)